2020
DOI: 10.1172/jci.insight.134638
|View full text |Cite
|
Sign up to set email alerts
|

Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(39 citation statements)
references
References 48 publications
0
38
1
Order By: Relevance
“…12,22 While this approach proved to be feasible in a number of patient studies, 33,34 it may not be possible in all patients, as exemplified in another study, where some volunteers had to be scanned in a supine position because of space restrictions. 35 The use of a respiratory belt or navigator for real-time or retrospective respiratory gating is also not without problems (eg loss of signal from respiratory belt or low-quality navigator signal because of B 0 and B 1 inhomogeneities, especially at high field) and leads to increased scan times. 36 For the VAPOR-STEAM spectra, the performance of the frequency correction was not optimal in 54% of the data sets for subjects with liver lipid contents lower than 2%, even though this was not directly apparent from the SNR and linewidth figures.…”
Section: Discussionmentioning
confidence: 99%
“…12,22 While this approach proved to be feasible in a number of patient studies, 33,34 it may not be possible in all patients, as exemplified in another study, where some volunteers had to be scanned in a supine position because of space restrictions. 35 The use of a respiratory belt or navigator for real-time or retrospective respiratory gating is also not without problems (eg loss of signal from respiratory belt or low-quality navigator signal because of B 0 and B 1 inhomogeneities, especially at high field) and leads to increased scan times. 36 For the VAPOR-STEAM spectra, the performance of the frequency correction was not optimal in 54% of the data sets for subjects with liver lipid contents lower than 2%, even though this was not directly apparent from the SNR and linewidth figures.…”
Section: Discussionmentioning
confidence: 99%
“…In agreement with lipidomic studies, 61,82 homozygous carriers had a greater hepatic PUI and a lower HOMA-IR compared to non-carriers despite all participants possessing hepatic steatosis. 116 From the opposing perspective, Fellinger et al 118 recently compared hepatic lipid composition between people with acromegaly and healthy controls. Notably, acromegaly is an endocrine disorder resulting from excessive growth hormone production and is characterised by insulin resistance despite having reduced liver fat content.…”
Section: Proton Magnetic Resonance Spectroscopy ( 1 H-mrs) Studiesmentioning
confidence: 99%
“…Notably, acromegaly is an endocrine disorder resulting from excessive growth hormone production and is characterised by insulin resistance despite having reduced liver fat content 119 . Accordingly, Fellinger et al 118 reported greater insulin resistance and lower hepatic lipids in people with acromegaly compared to healthy controls and this was accompanied by a lower proportion of unsaturated hepatic lipids. Therefore, these studies provide further human evidence of the dissociation between hepatic steatosis and insulin resistance, and support the notion that elevated saturated hepatic lipids, rather than total hepatic lipids, may be a more important determinant of the metabolic consequences of hepatic lipid accumulation.…”
Section: Hepatic Lipid Composition In Obesity‐related Metabolic Diseasementioning
confidence: 99%
“…As indicated above, GH-mediated lipolysis generates NEFA, which serves as a substrate for mitochondrial β (fatty acid) oxidation and ATP generation. In acromegalic subjects, hepatic lipid content is low and is associated with an increase in hepatic ATP synthesis rate as assessed by 31 P/ 1 H-7-T MR spectroscopy [171]. In addition, aHepGHRkd mice under basal conditions suppress the hepatic expression of carnitine palmitoyltransferase 1A (Cpt1a), independent of changes NEFA levels, or enhanced hepatic insulin signaling [59].…”
Section: Fatty Acid Oxidationmentioning
confidence: 99%